candidates bavituximab

Related by string. * candi dates . Candidates . Candidate . CANDIDATE . CANDIDATES : Democratic gubernatorial candidate . presidential candidate . Republican gubernatorial candidate . gubernatorial candidate Meg Whitman . gubernatorial candidate Nikki Haley / Bavituximab : bavituximab monotherapy trial . evaluating bavituximab . PS bavituximab . Peregrine bavituximab * *

Related by context. All words. (Click for frequent words.) 81 Cotara R 71 platforms GVAX 71 candidates Augment ™ 71 candidate XP# 69 polysaccharide polymer 69 targeted radiotherapeutic 69 sodium Injection 69 mGluR5 negative 69 candidate brentuximab vedotin 69 Cotara ® 69 orBec R oral beclomethasone 68 orBec ® oral beclomethasone 68 Aganocide 68 oral prodrug 68 candidate ridaforolimus 68 topically applied SEPA 68 oncolytic virus therapies 68 FOLOTYN ® 68 candidate deforolimus 68 Augment TM 68 Panzem R 68 Xcytrin R 67 BiovaxID TM 67 candidate epratuzumab 67 GVAX ® 67 lintuzumab SGN 67 allosteric modulator NAM 67 virus HCV protease inhibitor 67 targets Galectin receptors 66 include PLX IBD 66 CYT# potent vascular disrupting 66 Zemiva TM 66 ALN PCS 66 PNP inhibitor 66 molecular imaging radiopharmaceutical 66 candidates Azedra TM 66 candidate TNFerade biologic 66 IMPDH inhibitor 66 colorectal bladder 66 2 methoxyestradiol 66 refractory chronic lymphocytic 66 Staphylococcus aureus Immune Globulin 66 vaccines oncolytic virus 66 DNA RNA Medicines 66 Intravenous Human 66 Neulasta R 66 mitogen activated ERK kinase 66 Solazed TM 66 Amigal TM 66 candidate SILENOR TM 66 Crofelemer budesonide foam 66 pan histone deacetylase 66 methylnaltrexone bromide 66 CD# CEA 66 Locteron ® 65 Wafer polifeprosan 65 candidate ATHX 65 brand ciclesonide HFA 65 bucindolol hydrochloride 65 acetonide FA 65 investigational humanized monoclonal antibody 65 AAG geldanamycin analog 65 ocular formulation 65 include Altastaph TM 65 sapropterin dihydrochloride Tablets 65 novel VDA molecule 65 TRANSDUR ® 65 MCSP respectively 65 ELADUR ™ 65 motexafin gadolinium Injection 65 intravenous ghrelin agonist 65 TRANSDUR ™ 65 AzaSite Xtra 65 candidate AQ4N 65 treat male hypogonadism 65 inflammatory autoimmune diseases 65 dihydrochloride Tablets 65 IMiDs R 65 candidate AP# 65 Inc. AMEX YMI 65 Oracea TM 65 XL# anticancer compounds 65 lead molecular radiotherapeutic 65 personalized cellular immunotherapy 65 anticancer compound 65 mertansine 65 Genasense ® oblimersen 65 Disease IBD 65 Personalized Immunotherapy 65 candidate iSONEP TM 64 Tarvacin TM 64 recombinant subunit vaccine 64 selective immunoproteasome inhibitor 64 Injectable Bone Graft 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 R Saizen R 64 overactive bladder AA# 64 oxybutynin ATD TM 64 apricitabine ATC 64 candidates Azedra 64 acyclovir Lauriad R 64 arsenic trioxide injection 64 PDX pralatrexate 64 SPL# Gel vaginal microbicide 64 candidate HuCNS SC 64 targeting Inflammatory Bowel 64 Veronate R 64 MEK inhibitor RDEA# 64 alpha folate receptor 64 oral isotype selective HDAC 64 GlycoPEGylated hemostasis compounds 64 compound perifosine 64 cosmetic cosmeceutical products 64 mesylate tablets 64 Friedreich Ataxia FRDA 64 Empatic ™ 64 Evoltra ® 64 acne impetigo 64 Adagen ® 64 ALN TTR 64 FUSILEV ® 64 CDK cyclin dependent 64 gastro intestinal inflammation 64 kidney urologic 64 Kuvan TM sapropterin 64 investigational pharmacologically unique 64 P#X# antagonist 64 commercialize Aganocides 64 novel antifolate currently 64 R PEG uricase 64 ALN HPN 64 candidate Gencaro TM 64 Telik logo TELINTRA 64 rheumatoid arthritis thrombocytopenia 64 MT#/MEDI-# 63 developing ACAPODENE 63 Ovitrelle R Serostim 63 pipeline GlycoPEG GCSF 63 candidate CRLX# 63 topical non steroidal 63 Agonist MABA program 63 Phase Ib clinical trials 63 HYVISC ® treatment 63 IMiDs ® 63 VISICOL R 63 TSX YM AIM 63 ABL inhibitor 63 IAP inhibitor 63 SinuNase TM 63 5 FU leucovorin 63 Archexin 63 hypoxia activated prodrug 63 orally administered inhibitor 63 cutaneous T 63 RELOVAIR ™ 63 MKC# MKC# PP 63 HuCAL PLATINUM ® CysDisplay 63 S1P antibody 63 Intermezzo ® zolpidem tartrate 63 sapacitabine CYC# 63 INSPIRE Trial Phase III 63 include Phenoptin TM 63 accumulate preferentially 63 ALVESCO ® 63 label Lipofen R 63 EVIZON TM squalamine lactate 63 Zemiva ™ 63 drug GAP #B# 63 IMA# 63 NASH Huntington 63 PANVAC VF 63 pralatrexate injection folate analogue 63 individualized cellular immunotherapy 63 ZADAXIN ® 63 products Oncaspar ® 63 candidate Zenvia 63 Auxilium transmucosal film 63 proprietary HuCNS SC 63 evaluating picoplatin 63 Inhalation Aerosol 63 mocetinostat MGCD# 63 include Alferon N 63 LymphoStat B belimumab 63 vosaroxin 63 dipropionate 63 PLK1 SNALP 63 ionotropic glutamate receptor antagonists 63 ALTROPANE R 63 erlotinib Tarceva ® 63 investigational pan BCR 63 nasal calcitonin product 63 StaphVAX R 63 NS5b 63 NEBIDO VANTAS SUPPRELIN LA 63 PrevOnco ™ 63 omecamtiv mecarbil formerly 63 dasatinib Sprycel ® 63 DG# compounds targeting 63 highly purified pasteurized 63 Currently RegeneRx 63 ELADUR TM 63 Solution XOPENEX HFA 63 include Healive 63 R bendamustine hydrochloride 63 Celacade TM technology 63 Serostim ® 63 sorafenib tablets 62 phenylketonuria PKU developed 62 toenail onychomycosis 62 AzaSite Plus 62 Exherin TM 62 Prodarsan R 62 CYT# vascular disrupting 62 FACTIVE R gemifloxacin 62 Completes Patient Enrollment 62 non nucleoside inhibitor 62 Receives Orphan Drug Designation 62 rusalatide acetate 62 alvespimycin 62 Iluvien ® 62 AEG# 62 Injectable Suspension 62 SinuNase ™ 62 IMiDs ® compound 62 candidate NGX 62 systemic anaplastic large 62 Onalta TM 62 clinical trials dacetuzumab SGN 62 ONSOLIS TM 62 RAS MAPK pathway 62 Opterone R 62 antiangiogenesis therapies 62 Pruvel TM 62 TRAIL receptor antibodies 62 Cardium Therapeutics TM 62 Vidaza R 62 forodesine 62 IL# PE#QQR 62 Fludara ® 62 Peginterferon alfa 2b 62 Hsp# Inhibitor 62 oral nucleoside analogue 62 TOCOSOL Camptothecin 62 sodium thiosulfate STS 62 Zorbtive TM 62 Insegia 62 transthyretin mediated amyloidosis ATTR 62 Vicinium TM 62 5 lipoxygenase inhibitor 62 Phase IIb clinical trials 62 ATRA IV 62 therapeutic monoclonal antibody 62 GLP1 INT TM 62 ARRY # 62 docetaxel Taxotere R 62 recurrent metastatic ovarian cancer 62 oral ferric iron 62 ADP receptor antagonist 62 HGS ETR1 mapatumumab 62 investigational immunotherapy 62 dihydrochloride Phase 3 62 prokinetic agent 62 histone deacetylase HDAC inhibitor 62 * olmesartan medoxomil 62 product platforms AZX# 62 Fortical R 62 Initiates Phase II 62 Omacetaxine 62 XP# XP# 62 sapropterin dihydrochloride Phase 62 HCV polymerase inhibitors 62 Nexavar ® 62 DNA methyltransferase inhibitors 62 Aganocide ® 62 Orphan Drug designations 62 Myocet 62 including eniluracil ADH 62 novel histone deacetylase 62 TNFerade ™ 62 POSIDUR TM ELADUR TM 62 IMiDs 62 Solazed 62 aldehyde dehydrogenase ALDH2 deficiency 62 Luveris R Ovidrel R 62 JAK inhibitor 62 Vidaza ® 62 R sorafenib tablets 62 PORxin TM platforms 62 novel anti infective 62 Cleviprex TM clevidipine 62 Restoraderm R 62 drug ISA# 62 oritavancin semi 62 Copegus R 62 Kit CD# positive 62 candidate Zemiva 62 oral proteasome inhibitor 62 lenalidomide Revlimid R 62 PI3K/Akt pathway inhibitor 62 intravesical infusion therapy 62 histone deacetylase inhibitor 61 anti botulism antibody 61 Proxinium TM 61 LymphoStat B TM 61 XL# XL# XL# XL# 61 MKC# MT 61 Trastuzumab DM1 61 modified glutathione analog 61 novel L DOS# 61 Kosan dependence 61 clinical trials lintuzumab SGN 61 HCV protease inhibitor 61 Phase 2b Clinical Trial 61 Tezampanel 61 delivers fluocinolone acetonide FA 61 proprietary polysaccharide 61 Shigamabs R 61 Curaxin CBLC# 61 IRX 2 61 recombinant biopharmaceutical 61 Recombinant Human 61 agonistic human 61 sulfonylhydrazine class 61 Perflubutane Polymer Microspheres 61 miconazole Lauriad R 61 oral isoform selective HDAC 61 candidate Hematide TM 61 liposomal formulation 61 phase IIb clinical 61 multi kinase inhibitor 61 PORxin TM 61 muscarinic receptor agonist 61 evaluating tivozanib 61 Initiates Enrollment 61 Onalta 61 Shigamabs ® 61 Campath ® 61 cortisol synthesis 61 Panzem ® 61 Zalypsis 61 rxRNA 61 cardio renal 61 refractory gout 61 THR beta agonist 61 lorvotuzumab mertansine 61 Anturol ® 61 CK # novel 61 anti CD3 monoclonal 61 Exherin 61 treat opioid induced 61 essential thrombocythemia ET 61 TRIOLEX HE# APOPTONE HE# 61 biodefense pathogens 61 Phase #b/#a clinical 61 DPX Survivac 61 oncolytic 61 Nasdaq PGNX today 61 VEGFR2 inhibitor 61 topical antifungal product 61 LibiGel ® 61 NicVAX TM 61 dacetuzumab SGN 61 IMiD 61 Cetrorelix 61 candidate Zemiva TM 61 immunotherapeutic agent 61 Ixempra 61 Parkinson disease levodopa induced 61 Roche PEGASYS R 61 modulator SERM 61 RANK Ligand inhibitor 61 Generx TM 61 Besivance 61 HCl PEPCID ® famotidine 61 drug pipeline TAFA# 61 vapreotide acetate 61 Valortim TM 61 treat refractory angina 61 docetaxel Taxotere ® 61 PF # [002] 61 active AKT inhibitor 61 TPI ASM8 61 OvaRex R 61 CD# monoclonal antibody 61 Budesonide foam crofelemer 61 MOVIPREP R 61 NeuroSTAT ® 61 Application MAA 61 CTA# Injection 61 NOTE POSIDUR ™ 61 oxandrolone USP 61 PDE4 inhibitor 61 Alfacell proprietary ribonuclease 61 faropenem medoxomil 61 Amgen Neulasta R 61 Azedra 61 RhuDex ® 61 BrachySil 61 tiapamil 61 clinical trials SGN 61 non porcine pancreatic 61 JOULFERON 61 Thrombin topical Recombinant 61 MEK inhibitor 61 signal transduction inhibitor 61 HCV NS5B polymerase 61 Nicotine Conjugate Vaccine 61 Dapagliflozin 61 CD4 monoclonal antibody 61 candidate EFAPROXYN TM 61 TM Aganocide 61 Pruvel 61 metaglidasen 61 Cloretazine ® 61 Epothilone D 61 Oral NKTR 61 COLAZAL R 61 RNAi therapeutic targeting 61 RON Notch 60 sarcoma melanoma 60 Vascular Wrap TM 60 topical anti infective 60 JZP 60 compound PMX # 60 Kuvan R 60 triggers apoptosis programmed 60 investigational hepatitis C 60 Pruvel ™ 60 Lenocta TM 60 sulodexide 60 oral ridaforolimus 60 subcutaneous formulation 60 reslizumab 60 MT# MEDI 60 RNAi therapeutic 60 paclitaxel Taxol ® 60 MAGE A3 ASCI 60 2 inhibitor CYT# 60 telomerase inhibitor drug 60 triple VEGF receptor 60 product candidate Lpathomab 60 candidate Puricase 60 hormone LHRH antagonist 60 IgG1 monoclonal antibody 60 investigational mTOR inhibitor 60 Phase III Clinical Trial 60 monoclonal antibody conjugated 60 investigational monoclonal antibody 60 oral dual endothelin 60 Combination REOLYSIN R 60 multicenter Phase III 60 Solzira TM 60 BEMA Granisetron 60 cancer indications bafetinib 60 therapy Tovaxin 60 LEP ETU 60 SPRYCEL ® 60 XmAb ™ 60 Bazedoxifene 60 product Fentanyl TAIFUN 60 HCD# [002] 60 programs AN# topical 60 compound ISA# 60 intranasal vaccines derived 60 generation DACH Platinum 60 candidate MyVax 60 Protexia ® 60 small molecule chemopotentiator 60 TELINTRA 60 Solazed ™ 60 huC# DM4 60 autologous cellular immunotherapy 60 vinca alkaloid 60 hypoxia selective 60 using Innocoll proprietary 60 Bilive R combined 60 sores onychomycosis nail 60 Augment ™ 60 Copegus ® 60 MSCRAMM ® 60 refractory cutaneous T 60 ospemifene 60 Soliris TM eculizumab 60 aplastic anemia AA 60 platinum chemotherapeutic 60 small molecule thrombopoietin 60 overactive bladder VANTAS R 60 Navelbine ® 60 somatropin Kuvan R 60 Lubiprostone 60 Neo Urinary Conduit 60 PEGylated Fab fragment 60 MEK Inhibitor 60 IAP inhibitors 60 R rilonacept Injection 60 Aganocide R 60 huN# DM1 60 GVAX R 60 RNAi Therapeutic 60 include LibiGel ® 60 Immunotherapeutic 60 Cintredekin Besudotox 60 compound INCB# 60 Tibotec Therapeutics division 60 Vascular Disrupting Agent 60 HyperAcute 60 Factor VIIa Factor VIII 60 non alcoholic steatohepatitis 60 JAK1 60 interferon beta 1a infertility 60 sunitinib Sutent ® 60 PMX # PolyMedix 60 RECOTHROM ® 60 thrombin component 60 PHX# 60 defensin mimetic antibiotic 60 Genasense R oblimersen 60 Meets Primary Endpoint 60 TKB# 60 candidate REP# 60 Ceflatonin R 60 Initiate Clinical Trial 60 Microplasmin 60 PROVENGE sipuleucel T 60 investigational antiplatelet agent 60 Mg Usa 60 Viread tenofovir disoproxil fumarate 60 visit www.genenews.com 60 diagnostic radiopharmaceutical 60 novel emulsion formulation 60 cyclobenzaprine hydrochloride extended 60 Orally administered 60 aerosolized AAT 60 sodium glucose transporter 60 tumors GIST 60 Through Glycoscience R 60 Virulizin ® 60 highly selective inhibitor 60 PSMA ADC 60 Amplimexon 60 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 60 R memantine HCl 60 damage cirrhosis liver 60 antibody MAb 60 agent bevasiranib 60 Gemzar ® 60 HQK 60 lucinactant 60 oral deforolimus 60 investigational oral inhibitor 60 nasal decolonization 60 HYVISC R 60 utilizes InSite Vision 60 Initiates Clinical Trial 60 treats acute lymphoblastic 60 ZEVALIN ® 60 herpetic keratitis 60 Alferon LDO 60 VIVITROL ® 60 personalized immunotherapy 60 Phase 2b clinical trials 60 subsidiaries visit http:/www.apricusbio.com 60 PEG SN# 60 Resten NG 60 MYDICAR ® 60 stromal cells MSCs 60 mesylate tablets approved 60 FOLFOX6 chemotherapy regimen 60 Allovectin 7 60 Panzem NCD 60 Small Modular SMIP 59 Locteron exclusively 59 immunotherapeutic 59 treat lupus renal 59 TRO# 59 Alocrest 59 antibody MT# 59 HuMax 59 acting fibrinolytic 59 Onconase 59 REMOXY R 59 Allovectin 7 r 59 sapropterin dihydrochloride 59 VitiGam 59 forodesine HCl 59 ALN TTR# 59 hyperphenylalaninemia HPA due 59 Tesetaxel 59 pentadentate logo R 59 dihydrochloride 59 miconazole Lauriad 59 candidate Imagify TM 59 dependent kinase inhibitor 59 BEMA TM Fentanyl 59 oral beclomethasone dipropionate 59 investigational HCV polymerase 59 TFChem licenses 59 OncoVex 59 Panzem R NCD 59 D aspartate NMDA receptor 59 MyVax R 59 albiglutide 59 AQ4N 59 PROVENGE ® 59 phase IIb trial 59 Annamycin 59 commercialize deforolimus 59 StromaCel Inc. 59 Omigard 59 iloprost synthetic compound 59 evaluating satraplatin 59 relapsed leukemia 59 Exelixis compounds 59 DP VPA 59 Marqibo TM 59 lexidronam injection 59 NSE SUNPHARMA 59 Viprovex R 59 AAG KOS 59 GW# [003] 59 DNA demethylating agent 59 platform HDL Mimetic 59 OvaRex ® MAb 59 cathepsin K inhibitor 59 VentiRx Pharmaceuticals 59 fluoroquinolone class 59 sumatriptan DosePro 59 proven DuraSite ® 59 patented Bioral 59 bevacizumab Avastin ® 59 Nventa proprietary CoVal 59 PRN FDA Approves 59 CysDisplay R 59 Safinamide 59 GEM OS2 59 Sudhir Agrawal D.Phil 59 PEGylated interferon 59 ovarian esophageal 59 KALBITOR ® 59 Vidofludimus 59 octreotide implant 59 ASONEP TM 59 reversible inhibitor 59 deforolimus 59 PEGylated anti 59 Intarcia 59 small molecule defensin 59 rNAPc2 59 QUADRAMET R 59 novel orally administered 59 Selective Electrochemical Tumor Ablation 59 areas Fertility Transplantation 59 Polymer Microspheres 59 Oral Calcitonin 59 www.polymedix.com 59 registrational 59 plus Copegus R 59 Files IND 59 liver colon rectal 59 NS5B polymerase 59 elotuzumab 59 ONCASPAR 59 fibrosis IPF 59 KNS # 59 candidate Lovaxin C 59 Xeloda ® 59 delta opioid receptor 59 successfully commercialize Iluvien 59 Quinamed 59 memantine HCl 59 Civacir 59 Leukine ® 59 seliciclib CYC# 59 tizanidine hydrochloride short 59 Allovectin 7 R 59 particularly SANCTURA XR 59 NPC 1C 59 Imprime PGG ® 59 humanized therapeutic 59 By JAMAAL ABDUL 59 trastuzumab Herceptin R 59 3 registrational trial 59 peptidic compound 59 novel DACH platinum 59 Staphylococcus aureus Polysaccharide Conjugate 59 Cytogen marketed 59 application sNDA 59 novel synthetic PEGylated 59 phenylalanine ammonia lyase 59 allosteric modulator 59 TRISENOX ® 59 gastrointestinal stromal 59 Empatic TM 59 HuCNS SC ® 59 Crofelemer 59 OMNARIS HFA 59 Zenvia ™ 59 ® bortezomib 59 CCR9 antagonist 59 Genasense oblimersen sodium Injection 59 % uracil topical 59 Alzhemed TM 59 XOPENEX R 59 rilonacept Injection 59 tubulin inhibitor 59 signal averaging electrocardiography 59 telomerase therapeutic 59 Phase IIb Trial 59 Pigment containing 59 Ovidrel R Ovitrelle R 59 ThermoDox R 59 APC Targeting Technology 59 oral JAK#/JAK# inhibitor 59 dextofisopam 59 mGluR2 positive 59 based pretargeting methods 59 QNEXA ® 59 CDP# 59 Emergent marketed 59 PREOS R 59 Nexavar sorafenib 59 Pivotal Phase III 59 R famotidine 59 cetuximab Erbitux R 59 Nanobody R 59 TELINTRA R 59 MGCD# [001] 59 Provectus Pharmaceuticals specializes 59 CORLUX CORT # 59 novel antiviral therapeutics 59 MP4 molecule 59 PROGENSA R 59 Loramyc R 59 personalized dendritic cell 59 JAK2 inhibitor 59 urinary bladder wall 59 #/#/# Cytokinetics Incorporated 59 Zolinza 59 Tanespimycin 59 Predictive medicine 59 progressive metastatic prostate 59 thymalfasin 59 Lymphoseek ® 59 OctoPlus licensed 59 rALLy clinical trial 59 Amrubicin 59 NEUPOGEN 59 Zemiva TM Trofex TM 59 oral ghrelin agonist 59 TNFerade TM 59 FDA APPROVES 59 miconazole Lauriad ® 59 human C1 inhibitor 59 Phase III Pivotal 59 adjuvant GIST 59 Medoxomil 59 Irinotecan 59 CRMD# 59 Generx ™ 59 isoform selective 59 DURIN TM 59 relapsed refractory multiple myeloma 59 include BioNeutralizers 59 OTCBB PYTO 59 registrational trial 59 ACAPODENE TM 59 gastrointestinal disorders ATI 59 SYCREST 59 pancreatic colon 59 SinuNase TM novel 59 cachexia anti infectives 59 malignant mesothelioma Alfacell 59 CINQUIL 59 pseudobulbar affect PBA 59 EV# vaccine 59 Factor VIIa 59 novel orally inhaled 59 acetylgalactosamine 6 59 mitiglinide 59 HDAC Inhibitor 59 thetreatment 59 cardiometabolic diseases Glucophage 59 Novel Oral 59 INxin TM 59 Ceflatonin ® 59 5 HT3 antagonist 59 granulated mesalamine 59 Phase 2a Clinical Trial 59 darinaparsin ZIO 59 polyneuropathy HIV DSP 59 AFREZZA TM 59 Tarmogen 59 carcinoma mCRC 59 phase III isavuconazole 58 Bone Graft 58 Epirubicin 58 T Pred 58 HGS# 58 Entereg R 58 PEG PAL PEGylated recombinant 58 peptibody 58 Qutenza TM 58 tranquilizers diazepam 58 Metastatic Melanoma 58 Aerosurf 58 apoptosis proteins 58 orally bioavailable mimics 58 XmAb ® 58 pharmacogenomic translational research 58 Onalta ™ 58 erlotinib Tarceva R 58 trial evaluating PRX# 58 ZK EPO 58 TO AVOID PREGNANCY WHILE 58 apoptosis inducer 58 Gel repository corticotropin injection 58 tivozanib AV 58 CORT # 58 CYP#A# CYP#D# 58 vaccine GRNVAC1 58 carcinoma HCC 58 Microspheres 58 Vaccine Adjuvant 58 OTCBB HXBM developer 58 class anticancer quinolone 58 non nucleoside HCV 58 Locked Nucleic Acid 58 Onco TCS 58 Gentamicin Surgical Implant 58 6 sulfatase 58 REPRONEX ® menotropins 58 VisionDirect.com TM 58 R vancomycin hydrochloride 58 ferumoxytol Injection 58 nilotinib Tasigna ® 58 Zicam Cold Remedy RapidMelts 58 Inc Therapeutic Competitors 58 Kristalose ® lactulose 58 Panzem 58 Lenocta 58 cisplatin gemcitabine 58 TNF Tumor Necrosis Factor 58 Phase Ib II 58 R roscovitine CDK cyclin 58 developing Zerenex TM 58 MTP inhibitor 58 cell lymphoma CTCL 58 dextromethorphan quinidine 58 ApoB SNALP 58 zileuton tablets 58 JAK2 Inhibitor 58 BENLYSTA ™ 58 phase Ib clinical 58 DURECT proprietary 58 Dementia Related Psychosis 58 Initiates Phase III 58 Adenoscan R 58 Azedra TM Onalta TM 58 Mg Uk 58 NEUGENE antisense compound 58 Aflibercept 58 bevacizumab Avastin R 58 TRACON Pharmaceuticals 58 include Healive TM 58 oropharyngeal candidiasis 58 investigational compounds 58 Ganciclovir 58 Pharmacokinetics PK 58 Hepatitis C HCV 58 Azedra TM 58 Phase 2a clinical trials 58 HDL Mimetic Peptide 58 HyACT 58 MetroGel 58 EGFR expressing mCRC 58 Biopharmaceuticals AG 58 granted Ortec 58 BENLYSTA TM 58 product Hextend ® 58 cromolyn sodium 58 RECOTHROM R 58 chemotherapy induced neutropenia 58 investigational oral hepatitis C 58 post herpetic neuralgia PHN 58 AMMONUL R sodium phenylacetate 58 leading oral taxane 58 relapsed multiple myeloma 58 Aplidin R 58 Phase 2b Trial 58 palonosetron hydrochloride Injection Dacogen 58 Demonstrates Sustained 58 PrevOnco 58 Presents Positive 58 diarrhea predominant irritable 58 ASONEP 58 Genasense ® 58 Hedgehog Pathway Inhibitor 58 Prochymal TM 58 reformulates existing FDA 58 Vivecon 58 Application BLA 58 monoclonal antibody IgG1 Mab 58 lexidronam injection PROSTASCINT 58 targeted antifolate 58 LungCAD TM software 58 inhaled formulation 58 alfa 2a 58 Soliris eculizumab 58 inhibit angiogenesis 58 VALSTAR 58 delivery polymer matrix 58 Sulonex TM 58 RELISTOR ® 58 dyskinesia PD LID 58 Liprotamase 58 Epivir R 58 next generation URAT1 58 Brentuximab Vedotin SGN 58 KL4 Surfactant 58 Septin9 biomarker 58 mequinol 58 active cellular immunotherapy 58 adecatumumab MT# 58 VALSTAR R 58 Fodosine 58 Epivir HBV R 58 Traficet EN 58 ILUVIEN ® 58 Atripla combines 58 selective androgen receptor modulators 58 AKT inhibitor 58 catheter occlusion 58 synthetic retinoid 58 Tarceva TM 58 Phase IIa trials 58 Pivotal Phase 58 BYETTA ® 58 receptor tyrosine kinase inhibitor 58 www.soligenix.com 58 Nanobody 58 R lenalidomide 58 CIMZIA ™ 58 Locked Nucleic Acid LNA 58 developing ostarine selective 58 Surfaxin LS 58 HepeX B TM 58 ulimorelin 58 anticancer compounds 58 chimeric monoclonal antibody 58 ONCONASE R 58 OMP #R# 58 Phase IIb trials 58 radiation sensitizer 58 Vytorin combines 58 Palifosfamide 58 Endologix Powerlink System 58 Nucleic Acid Detection Immunoassay 58 PROSTASCINT R 58 iobenguane 58 ENMD # 58 adenosine injection 58 pathophysiological effects 58 inhibit oxidative stress 58 Through Glycoscience 58 FUSILEV enhances 58 Cellegesic 58 class mGluR5 inhibitor 58 GVAX cancer 58 Alseres Cethrin 58 Sphingomab TM 58 IV APAP 58 R MSCRAMM 58 itraconazole Sporanox 58 commercializing oxidized glutathione 58 Drug Candidate 58 Phase 2a clinical 58 monoclonal antibody MAb 58 serine protease inhibitor CU# 58 Ceragenin ™ 58 commercialize SGN 58 HuMax TAC 58 MEDAREX 58 triciribine phosphate monohydrate 58 bardoxolone 58 interferon gamma 1b 58 delay bone metastases 58 male hypogonadism PRO 58 Behcet uveitis 58 electrolytically generated source 58 selective androgen receptor modulator 58 sulfonylurea glimepiride 58 B Anflu R 58 Phase 1b clinical trials 58 Troxatyl 58 Topical Solution 58 active moiety 58 therapeutic monoclonal antibodies 58 5 HT2A inverse 58 Veronate

Back to home page